US chemicals group DuPont has secured the backing of Danisco shareholders for its bid to buy the Danish food ingredients group.

DuPont chair and CEO Ellen Kullman said today (16 May) she was “delighted” that the company had won over enough Danisco investors for its offer to be accepted.

Danisco shareholders rejected DuPont’s initial bid, which was tabled in January and worth DKK665 a share, valuing the company at US$5.8bn. Three weeks ago, DuPont put forward its “best and final” offer of DKK700 a share, or $6.44bn. DuPont also reduced the level of support it needed from Danisco shareholders, from 90% to 80%.

There had been some speculation that DuPont’s offer revised bid may not prove successful after US hedge fund Elliott Associates took its stake in Danisco above 10%.

“We are delighted that the tender has been successful and we can move on to the process of integrating Danisco into DuPont,” Kullman said. “Danisco’s attractive specialty food ingredients businesses and Genencor’s leading industrial enzymes complement DuPont’s own nutrition and health and applied biosciences offerings. This combination will create an industry leader in industrial biosciences and nutrition and health.”

Danisco’s board had backed both offers and chairman Jorgen Tandrup said the company was “very pleased” that the “vast majority” of the group’s investors had accepted DuPont’s offer.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.